Increasing Trauma/LOQTEQ® sales in Q3/2013, empiric observations show favorable behavior of LOQTEQ®

(PresseBox) ( Berlin, )
Preliminary figures indicate that aap Implantate AG (XETRA: AAQ.DE) achieved sales in the third quarter of 2013 of EUR 8.8 million (+2%; previous year: EUR 8.6 million). These figures are in line with the given forecast from august. Therefore, total sales in the first nine months increase by 3% to EUR 28.4 million (previous year: EUR 27.5 million).

It must be emphasized that sales in the Trauma segment increased by 53% (compared to the third quarter of 2012) and by 63% compared to last years first nine months. Trauma sales increased from EUR 1.5 million (Q3/2012) to EUR 2.3 million and from EUR 4.0 million (9m/2012) to EUR 6.5 million in the first nine months of 2013 respectively. The strong sales growth was driven mainly by sales in SMIT and BRICS countries. The first explantations of our LOQTEQ® plates show certain advantages compared to established competitive products, especially relating to the so called cold welding issue (a joining of the plate and the screw which complicate the proper removal of the implant). So far, no such complaints have been filed to aap for any LOQTEQ® product. In an ongoing in-vitro study, this empirical and highly relevant feature is to be explored further to be able to make a statistical proven and evidence-based statement.

Sales for bone cements and cementing techniques in the Biomaterials segment begin to speed up after the temporary reduction in the first half of 2013. During the fourth quarter, a full recovery is expected.

The evaluation process of the strategic options for EMCM is ongoing.

aap plans to publish the full Q3 2013 report on November 11, 2013.

Forward-looking statement

This release may contain forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of future performance. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Many factors could cause the actual results, performance or achievements of aap to be materially different from those that may be expressed or implied by such statements. These factors include those discussed in aap's public reports. Forward-looking statements therefore speak only as of the date they are made. aap does not assume any obligation to update the forward-looking statements contained in this release or to conform them to future events or developments.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to